arrow
N

Nicola Silvestris

istituto di ricovero e cura a carattere scientifico istituto tumori giovanni paolo ii
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM)

在癌症患者的多学科管理中计算机断层扫描的请求和报告模型:意大利医学和介入放射学会(SIRM)与意大利医学肿瘤学会(AIOM)的共识

2026-07-070
OAAI
Sex-Related Safety Signals of Sotorasib in Non-Small Cell Lung Cancer: A Real-World, Pharmacovigilance Study from the EudraVigilance Database

索托拉西布在非小细胞肺癌中的性别相关安全信号:一项来自EudraVigilance数据库的真实世界药物警戒研究

2026-03-030
OAAI
Genetic Insight into Expression-Defined Melanoma Subtypes and Network Mechanisms: An in Silico Study

基于基因分析的表型定义黑色素瘤亚型及网络机制研究:一项计算机模拟研究

2025-11-300
OAAI
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management

神经内分泌肿瘤骨转移:一项关于自然史和管理的意大利全国性调查结果

2025-11-180
OAAI
Clinical relevance and methodological approach for the assessment of drug–drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)

癌症患者药物相互作用评估的临床相关性与方法学路径:意大利医学肿瘤学会(AIOM)和意大利药理学学会(SIF)的立场声明

2025-06-010
OA
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey

意大利医学肿瘤学会(AIOM)加里波第调查中转移性队列的生存分析

2024-11-010
OAAI
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
2024-07-010
OAAI
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
2024-06-276
OAAI
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024-05-010
OAAI